NFKB1 and breast carcinoma: In the present study, we found that AT-I could inhibit the mammary tumorigenesis in rats, and the underlying mechanisms were further elucidated by detecting the effects of AT-I on TLR4/NF-κB pathway, and its downstream proinflammatory factors in breast cancer rats.